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Abstract 
Cardiac  magnetic  resonance  imaging
(MRI)  is  increasingly  used  as  the  optimum
modality for cardiac imaging. An aging popula-
tion and rising numbers of patients with per-
manent pacemakers means many such indi-
viduals may require cardiac MRI scanning in
the future. Whilst the presence of a permanent
pacemaker is historically regarded as a contra-
indication to MRI scanning, pacemaker sys-
tems have been developed to limit any associ-
ated  risks.  No  reports  have  been  published
regarding the use of such devices with cardiac
MRI in a clinical setting. We present the safe,
successful cardiac MRI scan of a patient with
an MRI-conditional permanent pacing system.
Introduction
Magnetic resonance imaging (MRI) gives
superior imaging resolution and is increasing-
ly the modality of choice for functional and
anatomical  imaging  in  cardiovascular  dis-
ease.1 In an aging population the prevalence
of patients with implanted trans-venous pac-
ing  systems  means  that,  increasingly,  such
patients will require a cardiac MRI study; how-
ever, the presence of a permanent pacemaker
(PPM)  has  traditionally  excluded  MRI  as  a
viable imaging modality.
The use of MRI as a viable and safe imaging
modality  for  individuals  with  an  implanted
PPM has been an issue of debate for some
time.2 There is increasing evidence that MRI
can  be  considered  safe  in  certain  circum-
stances.3,4 However, there are reports of haz-
ards both to the device and the patient, includ-
ing fatalities.2,5-10 Historically, the main con-
cerns  centered  around  the  potential  for  the
strong  magnetic  fields  to  move  the  device,
cause  inappropriate  pacemaker  stimulation,
potential  alterations  to  the  device  program-
ming,  and  to  create  cardiac  tissue  damage
through local heating with consequent alter-
ation in lead thresholds.
Confidence  has  improved  following  the
recent  advent  of  MRI  conditional  systems,
approved and CE marked for conditional use
with  MRI  scanning,  including  cardiac  MRI.
Whilst MRI scanning of anatomy remote to the
heart has been increasingly reported,9 there
remains  a  reluctance  to  use  MRI  fields  to
directly image the heart and thorax. Indeed,
initial recommendations involved keeping the
pacing device away from the isocenter of the
magnet,  hence  precluding  cardiac  imaging.
The concern was that the risk of damage to the
device or the patient would be too high if the
magnetic field was concentrated directly over
the heart, as well as the increased potential
for  artefact  attenuation  of  image  quality.
However, despite growing evidence to support
the safety of these devices in MRI scanning of
the heart under experimental conditions,9 to
our knowledge there are no published reports
regarding their use with cardiac MRI in a clin-
ical setting. 
Case Report
A 64-year old man presented with a history
of increasing exertional breathlessness, chest
tightness  and  intermittent  fatigue  shortly
after undergoing left atrial ablation for parox-
ysmal atrial fibrillation (AF). Following an ini-
tial diagnosis of AF in 2005, medical manage-
ment  with  anti-arrhythmic  drugs  (including
amiodarone) had been effective, but worsen-
ing symptoms necessitated left atrial ablation
with  pulmonary  vein  isolation  in  2009.
Subsequent  to  this,  he  reported  increasing
breathlessness and chest discomfort. 
Due to persistent symptomatic sinus brady-
cardia,  he  underwent  insertion  of  a  perma-
nent  pacemaker  system  in  February  2010.
Given his ongoing symptoms and the uncer-
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Figure 1. Chest X-ray, enlarged image of gen-
erator box. Radio-opaque labels are present
on the lead (large circle) and device (smaller
circle) to indicate that the device can be used
with magnetic resonance imaging.Case Report
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tainty of the underlying diagnosis, the pacing
system selected for implant was a Medtronic
EnRhythm MRI™ SureScan™ dual chamber
device and CapSureFix MRI™ leads (Figure
1).  This  pacing  system  (generator  box  and
leads) is the first to be designed to be compat-
ible with MRI scanning under pre-defined con-
ditions;11 in general terms, these conditions
include  marginal  limitation  of  the  magnetic
field and ensuring that the pacemaker is well
established and functioning reliably. 
The patient’s past medical history included
Wolf-Parkinson-White  syndrome,  with  suc-
cessful ablation of a right free wall accessory
pathway in 1995, moderate aortic valve regur-
gitation,  essential  hypertension,  benign  pro-
static hyperplasia, obesity (BMI=37) and mild
psoriasis.  Physical  examination  revealed  a
regular paced rhythm, quiet aortic stenotic and
regurgitant  murmurs,  and  clear  lung  fields.
Trans-thoracic  echocardiography  provided
non-diagnostic  images  as  a  consequence  of
body habitus. Coronary angiography four years
previously  had  demonstrated  no  significant
coronary disease.
In  view  of  the  wide  differential  diagnosis
and the patient’s previous exposure to high-
dose  ionising  radiation,  MRI  scanning  was
considered  the  most  appropriate  imaging
modality  to  gather  information  on  coronary
perfusion,  left  ventricular  function,  valvular
status,  pericardial  constraint  and  pulmonary
venous  anatomy  in  a  single  imaging  proce-
dure, free of further ionising radiation. 
Cardiac magnetic resonance imag-
ing scan
The scan was performed according to a local
protocol designed to closely follow the condi-
tions of use published by the manufacturers of
the device.11 Close liaison with the manufac-
turers’  technical  representatives  was  main-
tained  throughout.  A  1.5  T  magnetic  field
(Philips  Intera,  Philips  Healthcare,  the
Netherlands)  was  employed  and  specific
absorption rate (SAR) was kept to 1 watts/kg or
less; well beneath below the 2 watts/kg advised.
The device pocket had healed well over the pre-
vious  five  months  and  lead  thresholds  were
stable, comfortably below the stipulated cap-
ture thresholds of 2.0 volts at 0.4 millisecond
pulse width (Table 1). As the patient was not
dependent  on  pacing,  the  device  was  pro-
grammed to the manufacturers’ advised set-
ting of ODO (i.e. sensing only, not pacing) dur-
ing  the  scan,  with  continuous  non-invasive
hemodynamic monitoring. The patient experi-
enced  no  abnormal  sensations  during  the
scan. The device sensing and pacing parame-
ters  pre-  and  immediately  post-scan  did  not
change  to  any  significant  degree  (Table  1).
Subsequent pacing checks also proved unre-
markable, with no undue changes to battery
longevity.
Diagnostic  quality  images  were  acquired,
including first pass adenosine stress perfusion
imaging,  and  early  and  late  gadolinium
enhanced imaging. A minor degree of artefact
was reported due to dephasing (Figures 2 and
3) which did not compromise the quality of
data interpretation.
The  scan  comprehensively  evaluated  both
anatomy  and  function  without  the  need  for
ionising radiation and without compromising
the image quality. The LV dimensions and con-
tractility were normal, as was the stress perfu-
sion scan. Flow velocity imaging showed mild
aortic  stenosis  with  moderate  regurgitation.
The pulmonary veins were shown to be free of
stenosis.
Table 1. Characteristics of the pacing leads before and immediately after the scan.
Pre-scan Post-scan
Atrium Ventricle Atrium Ventricle
Threshold @ 0.4 ms (V) 0.5 11 1
Sensing (mV) 3.3 7.8 3.9 7.6
Impedance (nms￿) 416 480 440 528
Figure 2. Still images taken from balanced steady state free precession (bSSFP) cine image
acquisition.  Trans-axial view of the heart (left hand panel) showing lead artefact (arrow)
in the right atrium (RA) and right ventricle (RV).  Trans-axial view of the pre-pectoral
pocket (right hand panel) showing artefact from the pacemaker generator box (arrow):
artefact did not compromise the quality of data interpretation. 
Figure 3. (A) Four chamber orientation of
the heart using black blood imaging show-
ing a small amount of artefact in the right
atrium. (B) Still image from a bSSFP cine
clip showing excellent resolution with only
minimal  artefact.  (C)  Late  gadolinium
enhanced imaging showing absence of left
ventricular  scarring,  again  with  minimal
interference from the pacing leads.Case Report
[page 72] [Heart International 2011; 6:e19]
Conclusions
To our knowledge, this is the first report in a
clinical setting of the safe use of cardiac MRI to
investigate a patient previously implanted with
an  MRI  conditional  pacemaker.  Only  minor
adjustments were required to the usual scan-
ning  protocol  and  high  quality  diagnostic
images were readily obtained. Importantly, the
patient experienced no ill effects and there was
no change in pacemaker function. Whilst there
have been reports of MRI scans undertaken on
various  parts  of  the  anatomy,  including  the
heart,  of  individuals  with  pacing  devices,3,4
there have been justifiable concerns about risks
of MRI imaging with conventional pacemaker
devices.5-10We demonstrate that safe high qual-
ity cardiac MRI scanning with a dedicated MRI
conditional pacemaker device can be performed
safely and successfully in a clinical setting.
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